These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 28116918)

  • 1. Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.
    Muratore F; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2017 Apr; 13(4):345-360. PubMed ID: 28116918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing treatment options for large vessel vasculitis.
    Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological treatments in giant cell arteritis & Takayasu arteritis.
    Samson M; Espígol-Frigolé G; Terrades-García N; Prieto-González S; Corbera-Bellalta M; Alba-Rovira R; Hernández-Rodríguez J; Audia S; Bonnotte B; Cid MC
    Eur J Intern Med; 2018 Apr; 50():12-19. PubMed ID: 29146018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotherapies in large vessel vasculitis.
    Ferfar Y; Mirault T; Desbois AC; Comarmond C; Messas E; Savey L; Domont F; Cacoub P; Saadoun D
    Autoimmun Rev; 2016 Jun; 15(6):544-51. PubMed ID: 26883459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotherapies in large vessel vasculitis.
    Pazzola G; Muratore F; Pipitone N; Salvarani C
    Rev Med Interne; 2016 Apr; 37(4):274-8. PubMed ID: 26383765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advances in the treatment of large vessel vasculitides].
    Szabó MZ; Kiss E
    Orv Hetil; 2017 Jan; 158(1):5-12. PubMed ID: 28067080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of large vessel vasculitis].
    Alvarez-Hernández E
    Reumatol Clin; 2011 Dec; 7 Suppl 3():S28-32. PubMed ID: 22152287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
    Hellmich B; Águeda AF; Monti S; Luqmani R
    Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
    Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
    Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica.
    Spies CM; Burmester GR; Buttgereit F
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S172-7. PubMed ID: 21044455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the management of Takayasu arteritis.
    Misra DP; Wakhlu A; Agarwal V; Danda D
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():60-68. PubMed ID: 30698358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Large vessel vasculitis].
    Weigand S; Fleck M
    Z Rheumatol; 2014 Jun; 73(5):447-55; quiz 456-7. PubMed ID: 24924731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
    Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
    Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.
    Palmowski A; Buttgereit F
    Curr Rheumatol Rep; 2020 Oct; 22(12):85. PubMed ID: 33047263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab: a new therapy for large vessel vasculitis.
    Al-Homood IA
    Clin Exp Med; 2014 Nov; 14(4):355-60. PubMed ID: 23949338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab in the treatment of giant cell arteritis.
    Leuchten N; Aringer M
    Immunotherapy; 2018 Mar; 10(6):465-472. PubMed ID: 29504436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
    Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
    RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis.
    Koster MJ; Matteson EL; Warrington KJ
    Curr Opin Rheumatol; 2016 May; 28(3):211-7. PubMed ID: 26885650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.